Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?

被引:2
|
作者
Kyong Shin, Jung [1 ]
Ah Park, Yoon [1 ]
Wook Huh, Jung [1 ]
Hyeon Yun, Seong [1 ]
Cheol Kim, Hee [1 ]
Yong Lee, Woo [1 ]
Hyung Kim, Seok [2 ]
Yun Ha, Sang [2 ]
Cho, Yong Beom [1 ,3 ,4 ,5 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pathol, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[4] Sungkyunkwan Univ, Dept Biopharmaceut Convergence, Seoul, South Korea
[5] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, 81 Irwon Ro, Seoul 06351, South Korea
关键词
Adjuvant chemotherapy; High grade; Prognostic factor; Stage II colon cancer; Tumor budding; ADJUVANT SYSTEMIC CHEMOTHERAPY; COMPLETE RESECTION; COLORECTAL-CANCER; FLUOROURACIL; LEVAMISOLE; SURVIVAL; INDEX; RECOMMENDATIONS; EFFICACY; THERAPY;
D O I
10.1097/DCR.0000000000002345
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Risk factors, including lymphatic, vascular, and perineural invasion, are considered indications for adjuvant treatment in stage II colon cancer. However, tumor budding is not included in the above risk factors.OBJECTIVE: This study aimed to assess the value of tumor budding as a prognostic factor in stage II colon cancer. DESIGN: This is a retrospective cohort study.SETTINGS: This study was conducted in a tertiary referral center.PATIENTS: This study examined 1390 patients with stage II colon cancer who received curative resection from 2007 to 2013 at an institution.INTERVENTIONS: These patients were classified according to tumor budding status: low-grade tumor budding (less than 10 buds) and high-grade tumor budding (10 buds or more). Differences between the 2 groups were corrected by propensity score matching.MAIN OUTCOME MEASURES: Disease-free survival and overall survival were the primary end points.RESULTS: Among 1390 patients, 146 (10.5%) had highgrade tumor budding. The high-grade tumor budding group showed adverse histological characteristics such as advanced T stage, histological grade of differentiation, and presence of lymphatic/perineural invasion. After matching, the 5-year disease-free survival rate for the high-grade tumor budding group was significantly lower than for the low-grade group. We also compared survival outcomes according to tumor budding grade for patients who did not have risk factors and did not receive adjuvant treatment. The 5-year overall survival was similar between the 2 groups. However, the 5-year disease-free survival decreased significantly in the high-grade tumor budding group than in the low-grade tumor budding group. LIMITATIONS: This was a retrospective study with a single-center design.CONCLUSIONS: High-grade tumor budding is a poor prognostic factor in stage II colon cancer and is considered one of the risk factors for adjuvant treatment. See Video Abstract at http://links.lww.com/DCR/B962.
引用
收藏
页码:E801 / E808
页数:8
相关论文
共 50 条
  • [1] Immunohistochemical analysis of tumor budding in stage II colon cancer: exploring zero budding as a prognostic marker
    Kristensen, Maria Pihlmann
    Korsgaard, Ulrik
    Timm, Signe
    Hansen, Torben Frostrup
    Zlobec, Inti
    Kjaer-Frifeldt, Sanne
    Hager, Henrik
    [J]. VIRCHOWS ARCHIV, 2024,
  • [2] Association between tumor budding grade and T stage as prognostic value for recurrence with high-risk stage II colon cancer: A retrospective study
    Kodama, H.
    Yamaguchi, T.
    Ishizuka, N.
    Yukami, H.
    Aoki, M.
    Miyamoto, T.
    Terazawa, T.
    Kii, T.
    Goto, M.
    Hamamoto, H.
    Osumi, W.
    Yamamoto, M.
    Tanaka, K.
    Okuda, J.
    Higuchi, K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S223 - S223
  • [3] High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer
    Marx, Andreas H.
    Mickler, Claudius
    Sauter, Guido
    Simon, Ronald
    Terracciano, Luigi M.
    Izbicki, Jakob R.
    Clauditz, Till S.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (02) : 259 - 268
  • [4] High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer
    Andreas H Marx
    Claudius Mickler
    Guido Sauter
    Ronald Simon
    Luigi M Terracciano
    Jakob R Izbicki
    Till S Clauditz
    [J]. International Journal of Colorectal Disease, 2020, 35 : 259 - 268
  • [5] Is primary tumor location an independent prognostic factor in stage IV colon cancer?
    Yokoyama, Sachio
    Baba, Hideo
    [J]. JOURNAL OF THE ANUS RECTUM AND COLON, 2019, 3 (04): : 196 - 202
  • [6] Invasion is not an independent prognostic factor in high-grade glioma
    Narayana, Ashwatha
    Perretta, Donato
    Kunnakkat, Saroj
    Gruber, Deborah
    Golfinos, John
    Parker, Erik
    Medabalmi, Praveen
    Zagzag, David
    Eagan, Pat R. N.
    Gruber, Michael
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (03) : 331 - 335
  • [7] Prognostic impact of tumor budding in stage II colon cancer: A prospective study (SACURA trial).
    Ueno, Hideki
    Ishiguro, Megumi
    Nakatani, Eiji
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    Murotani, Kenta
    Matsui, Shigeyuki
    Tomita, Naohiro
    Shimada, Yasuhiro
    Takahashi, Keiichi
    Kotake, Kenjiro
    Watanabe, Masahiko
    Mochizuki, Hidetaka
    Teramukai, Satoshi
    Sugihara, Kenichi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Tumor budding and CDX2 as additional prognostic factors in stage II colon cancer
    Roberto, M.
    Ierino, D.
    Panebianco, M.
    Romiti, A.
    Di Cerbo, A.
    Falcone, R.
    Ferri, M.
    Balducci, G.
    Ramacciato, G.
    Pilozzi, E.
    Marchetti, P.
    Mazzuca, F.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S130 - S130
  • [9] High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk
    Huang, Bangxing
    Cai, Jing
    Xu, Xia
    Guo, Shuang
    Wang, Zehua
    [J]. PLOS ONE, 2016, 11 (11):
  • [10] Prognostic value of tumor budding in patients with stage II and III colon cancer: A singleinstitution experience.
    Vinal, David
    Rueda-Lara, Antonio
    Martinez-Perez, Daniel
    Zwisler, Patricia
    Garcia-Leal, Andrea
    Ruiz-Gutierrez, Iciar
    Jimenez-Bou, Diego
    Pena-Lopez, Jesus
    Alameda-Guijarro, Maria
    Martin-Montalvo, Gema
    Perez-Wert, Pablo
    Martinez-Recio, Sergio
    Elena Palacios, Maria
    Ghanem, Ismael
    Custodio, Ana B.
    Gutierrez-Sainz, Laura
    Feliu, Jaime
    Rodriguez Salas, Nuria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 247 - 247